Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Ophthalmic NSAIDs for Common Indications Compared

A recent review compared published data on the efficacy of several ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), within and outside their FDA-approved uses.

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Ocular Syphilis: What Clinicians Should Know

The Centers for Disease Control and Prevention (CDC) has issued a clinical advisory on ocular syphilis due to recent confirmed and suspected cases in several states.

Eye Complications Possible with Measles

In the midst of the current resurgence of measles across the United States, ophthalmologists are warning that even before the telltale skin rash appears, the infection typically shows up in the eyes.

FDA Expands Eylea Indication

The Food and Drug Administration (FDA) has granted expanded the use of Eylea (aflibercept; Regeneron) injection to treat diabetic retinopathy in patients with diabetic macular edema (DME).

Binocular Vision Linked to Increased Injuries

For older Medicare beneficiaries, having a disorder of binocular vision is associated with increased odds of musculoskeletal injury, fracture, and fall.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Retinitis Pigmentosa Gene Therapy: Orphan Drug

The FDA has granted Orphan Drug designation to RST-001 for the treatment of retinitis pigmentosa (RP).

News

Optina Efficacious in Diabetic Macular Edema Study

Ampio Pharmaceuticals announced positive results from the OptimEyes Trial for Optina in patients with diabetic macular edema (DME).

Efficacy of Ophthalmic NSAIDs for Common Indications Compared

A recent review compared published data from 67 articles on the efficacy of diclofenac, ketorolac, flurbiprofen, bromfenac, and nepafenac within and outside their FDA-approved uses.

Age-Related Macular Degeneration, Mortality Linked

Age-related macular degeneration (AMD) is a predictor of poor survival, especially among women aged 80 years and older, according to a study published online in the Journal of the American Geriatrics Society.

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Blurred vision - Red flag symptomsExternal web site

Blurred vision - Red flag symptoms

0.50 Credits

Pulmonology, Pediatrics, Ophthalmology, and ENTExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...

CME 4.50 Credits

Vitreomacular Traction, Macular Hole Treatment, and Injection TechniqueExternal web site

This webcast will discuss the pathophysiology and diagnostic criteria of VMA/VMT and treatment options for ...

CME 1.50 Credits

Sign Up for Free e-newsletters